window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Events and Conferences

  • Biomanufacturing,CDMOs & Manufacturing,Events and Conferences,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    March 6, 2026
  • Biotech,Cell & Gene Therapy,Drug Development,Events and Conferences

    ELRIG announces keynotes for inaugural Cell and Gene Therapy 2026 conference

    ELRIG has unveiled the keynote speakers for its inaugural Cell [...]

    January 26, 2026
  • CDMOs & Manufacturing,Drug Development,Events and Conferences,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPhI & PMEC India 2025 showcases pharma innovation and sets stage for expanded 2026 edition

    The 18th edition of CPhI & PMEC India, South Asia’s [...]

    January 12, 2026
  • Drug Delivery & Formulation,Events and Conferences,Manufacturing,Packaging,Sustainability

    Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging

    Pharmapack will return to Paris in January 2026, with this [...]

    January 8, 2026
  • Artificial Intelligence,Clinical Development,Data Management,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Pistoia Alliance warns of scientific content crisis limiting accuracy of AI in life sciences R&D

    The Pistoia Alliance has reported new findings pointing to a [...]

    December 3, 2025
  • Cell & Gene Therapy,Clinical studies,Clinical Trials,Events and Conferences,Hematology,Oncology,Pharmaceuticals and therapeutics

    CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting

    CytoAgents will present new clinical safety data for CTO1681 at [...]

    December 3, 2025
  • Chronic diseases,Events and Conferences,Global health,Obesity,Women's Health

    UAE obesity conference highlights global advances shaping the future of obesity care

    The 7th UAE Obesity Conference brought together international experts in [...]

    November 19, 2025
  • Events and Conferences,Facilities and infrastructure,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPHI & PMEC India 2025 returns to Delhi as South Asia’s largest pharma event

    CPHI & PMEC India will return to the India Expo [...]

    November 17, 2025
  • Dermatology,Events and Conferences,Immunology,Mental health,Patient Centricity,Pharmaceuticals and therapeutics

    Almirall ImmunoSkin brings experts together to advance treatment of inflammatory skin diseases

    Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

    November 12, 2025
  • Biologics & Biosimilars,Biotech,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Abselion launches His-tag protein quantification kit and sensors for Amperia at PEGS Europe 2025

    Abselion has expanded its Amperia assay portfolio with the launch [...]

    November 11, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top